Shanghai, China · Founded 2018 · Privately Held (backing)
Developer of medical hydrogel products intended to provide new medical solutions. Reunion Biotech is based in Shanghai, China and was founded in 2018. Its last reported valuation was $45.1 million in Dec 2021. It has raised $35.4 million.
Last reported valuation
$45.1M
Oct 2026
Priced at
—
Total raised
$35.4M
Last round
—
Cap table — not yet on record
Reunion Biotech's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Reunion Biotech with a free account
·Watch Reunion Biotech: the Monday email on marks, rounds and moves
